Clinical trial Recruiting at 1 site Observational Ages 18 and up

Fluid removal and sleep apnea changes in heart failure patients

Official title: The Impact of Volume Overload on Obstructive Sleep Apnea in Patients With Congestive Heart Failure

Run by Shaare Zedek Medical Center · NCT07601724 · Data updated 2026-11-12

This study tests whether removing excess fluid in adults with heart failure improves their sleep apnea while in the hospital.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorShaare Zedek Medical Center
Academic / other
Locations1 site (Jerusalem)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJanuary 2027
Study endsJune 2027
Registry record updatedMay 22, 2026
Trial IDNCT07601724 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older hospitalized for decompensated heart failure with fluid overload and able to undergo WatchPAT sleep assessment and provide consent.

Probably not a fit

Patients with central sleep apnea, those already on CPAP, or those unable to use the WatchPAT device may not experience sleep apnea benefit from the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows adults hospitalized with decompensated heart failure and fluid overload to see how diuresis affects obstructive sleep apnea measured with a WatchPAT device. Sleep apnea is assessed before and after fluid removal, with neck circumference, weight, and fluid balance recorded. The study also uses routine clinical data to explore potential relationships between fluid changes and sleep-disordered breathing. Findings may clarify whether fluid management influences sleep apnea severity in this patient population.

Why it matters

Potential benefit: If successful, results could inform fluid-management strategies to help mild-to-moderate sleep apnea in heart failure patients.

How similar studies have gone: Previous research in related areas suggests fluid status can influence sleep-disordered breathing, but this specific diuresis-sleep apnea relationship in hospitalized heart failure patients is not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older
* Hospitalized with decompensated heart failure and clinical evidence of fluid overload
* Diagnosis of heart failure (reduced or preserved ejection fraction)
* Clinically indicated for diuretic therapy
* Able to undergo sleep apnea assessment using the WatchPAT device
* Able to provide informed consent

Exclusion Criteria:

* Known central sleep apnea as the predominant sleep-disordered breathing type
* Current treatment with continuous positive airway pressure (CPAP)
* Acute respiratory failure requiring mechanical ventilation
* Conditions preventing proper use of the WatchPAT device (e.g., severe hand or finger injury)
* Hemodynamic instability precluding participation
* Pregnancy

Where it's running

  • Shaare Zedek Medical Center
    Jerusalem, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.